Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes

NCT05194592 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes
Remodeling, Ventricular

Interventions

DRUG: Dapagliflozin
DRUG: Gemigliptin

Sponsor

Wonju Severance Christian Hospital